ATE269904T1 - Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien - Google Patents

Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien

Info

Publication number
ATE269904T1
ATE269904T1 AT93908349T AT93908349T ATE269904T1 AT E269904 T1 ATE269904 T1 AT E269904T1 AT 93908349 T AT93908349 T AT 93908349T AT 93908349 T AT93908349 T AT 93908349T AT E269904 T1 ATE269904 T1 AT E269904T1
Authority
AT
Austria
Prior art keywords
expression
gramp
transport
positive bacteria
hybrid
Prior art date
Application number
AT93908349T
Other languages
English (en)
Inventor
Vincent A Fischetti
Gianni Pozzi
Olaf Schneewind
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE269904T1 publication Critical patent/ATE269904T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93908349T 1992-03-13 1993-03-12 Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien ATE269904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85108292A 1992-03-13 1992-03-13
PCT/US1993/002355 WO1993018163A2 (en) 1992-03-13 1993-03-12 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria

Publications (1)

Publication Number Publication Date
ATE269904T1 true ATE269904T1 (de) 2004-07-15

Family

ID=25309927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908349T ATE269904T1 (de) 1992-03-13 1993-03-12 Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien

Country Status (10)

Country Link
EP (1) EP0646176B1 (de)
JP (1) JP3626181B2 (de)
AT (1) ATE269904T1 (de)
AU (1) AU674311B2 (de)
CA (1) CA2131995A1 (de)
DE (1) DE69333560T2 (de)
DK (1) DK0646176T3 (de)
ES (1) ES2224097T3 (de)
HU (1) HU220420B (de)
WO (1) WO1993018163A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
ATE269904T1 (de) * 1992-03-13 2004-07-15 Univ Rockefeller Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
US5516637A (en) * 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
GB9518323D0 (en) 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
CA2365523A1 (en) 1999-04-15 2000-10-26 The Regents Of The University Of California Identification of sortase gene
US7101692B2 (en) 1999-04-15 2006-09-05 The Regents Of The University Of California Identification of sortase gene
US6365156B1 (en) 1999-04-16 2002-04-02 Osel, Inc. Method for improving the half-life of soluble viral-specific ligands on mucosal membranes
EP1984022A2 (de) * 2006-01-17 2008-10-29 CREATOGEN Laboratories GmbH Influenzaimpfstoff
IL208820A0 (en) * 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
WO2013044059A2 (en) * 2011-09-23 2013-03-28 Forsyth Dental Infirmary For Children A vaccine and therapeutic delivery system
US9925257B2 (en) 2011-09-23 2018-03-27 Forsyth Dental Infirmary For Children Vaccine and therapeutic delivery system
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2199932T3 (es) * 1989-06-21 2004-03-01 The Rockefeller University Poxvirus recombinante y vacuna estreptococica que contiene proteina m.
SE9101433D0 (sv) * 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use
ATE269904T1 (de) * 1992-03-13 2004-07-15 Univ Rockefeller Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien

Also Published As

Publication number Publication date
WO1993018163A2 (en) 1993-09-16
DK0646176T3 (da) 2004-11-08
AU3919993A (en) 1993-10-05
HU9402575D0 (en) 1994-11-28
ES2224097T3 (es) 2005-03-01
JP3626181B2 (ja) 2005-03-02
AU674311B2 (en) 1996-12-19
EP0646176B1 (de) 2004-06-23
EP0646176A1 (de) 1995-04-05
HU220420B (hu) 2002-01-28
DE69333560D1 (de) 2004-07-29
HUT70306A (en) 1995-09-28
WO1993018163A3 (en) 1993-11-11
CA2131995A1 (en) 1993-09-16
JP2002509421A (ja) 2002-03-26
DE69333560T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
ATE269904T1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
EP0245362A4 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK103085D0 (da) Hepatitis-b-peptidimmunogen
CA2080462A1 (en) Therapeutic uses of actin-binding compounds
ATE150319T1 (de) Behandlung von asthma
ATE91714T1 (de) Transformation von trichoderma.
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
SE8900899L (sv) Peptider foer diagnostisk anvaendning
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
PT93178A (pt) Agente proteico anticanceroso
ATE296887T1 (de) Hämorrhagie-virus aus kaninchen (rhdv), rekombinante hullen und dessen proteine, diagnosesätze und impfstoffe die sie enthalten
DE69011122D1 (de) Rubella-e1 und c peptide.
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
DE3854096D1 (de) Verfahren zur Isolierung von Basalmembranproteinen aus menschlichen und tierischen Geweben.
DE69513226D1 (de) Verwendung von Azolen als Virustötende Substanzen in Lösungen von biologisch aktiven Proteinen
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
ATE119166T1 (de) An hiv relatierte peptide.
Sarkar et al. Species specificity of ribosomal proteins in eucaryotic and procaryotic organisms
GB916455A (en) Non-toxic antigens and process for producing same
ES2108872T3 (es) Deteccion de anticuerpos especificos del virus del sarampion por medio de las proteinas recombinantes del sarampion.
DK547486A (da) Peptider samt praeparater indeholdende disse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0646176

Country of ref document: EP

REN Ceased due to non-payment of the annual fee